Star Trek: Starfleet Academy, the latest Star Trek series from CBS and executive producer Alex Kurtzman, follows a new ...

How this show is received could very well determine the future of Star Trek. That’s a lot to put on it, but there’s something ...

Starfleet Academy' follows on in the style of 'Discovery,' for better and occasionally worse—but builds something interesting ...

Star Trek tries to get a fresh start with Starfleet Academy, but it's dogged by the same pitfalls that have hampered recent Trek — read our review.

Starfleet Academy ’s far-future setting means the showrunners aren’t nearly as limited by existing series continuity, which ...

Don't miss 'The Curse of Rigel ' Expansion Launch Trailer for Wartales, an open-world turn-based strategy RPG developed by Shiro Games. Players will enforce the King's will to venture into the County ...

Rigel ( (RIGL)) has provided an announcement. On December 7, 2025, Rigel Pharmaceuticals announced updated data from its ongoing Phase 1b study of R289, an oral prodrug, in patients with relapsed or ...

Rigel Pharmaceuticals stock has seen its fair value estimate tick up to $49.60 from $46.60, underpinned by stronger long term revenue growth assumptions of about 9.8% versus 8.8% previously. At the ...

The latest series in the Star Trek franchise is Star Trek: Starfleet Academy. Some kind of Starfleet Academy project has been rumored since the ’80s, for both film and TV. But one is finally happening ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...